Skip to main content
    S

    Stryker Corporation (SYK)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $310.67
    +1.03 (+0.33%)

    Market Cap: $117.88B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Stryker Corporation (SYK) Financials: Revenue, Profit and Cash Flow

    Updated Oct 29, 2026. Financial statements from company filings, amounts in US dollars.

    Stryker reported revenue of $25.12B for the fiscal year ended Dec 31, 2025, up 11.2% from the year before. That year, net income was $3.25B with a net margin of 12.9%, operating cash flow was $5.04B and free cash flow was $4.28B. The quarter ended Sep 30, 2026 had revenue of $6.52B and net income of $753.00M.

    Revenue and Margins

    The operating margin was 19.5% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $11.32B, a compound annual rate of 9.3%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$25.12B+11.2%64.0%19.5%12.9%
    Dec 2024$22.59B+10.2%63.9%16.3%13.2%
    Dec 2023$20.50B+11.1%63.7%19.0%15.4%
    Dec 2022$18.45B+7.8%62.8%15.4%12.8%
    Dec 2021$17.11B+19.2%64.1%15.1%11.7%
    Dec 2020$14.35B-3.6%63.1%15.5%11.1%
    Dec 2019$14.88B+9.4%65.1%18.2%14.0%
    Dec 2018$13.60B+9.3%65.7%18.7%26.1%
    Dec 2017$12.44B+9.9%65.7%18.5%8.2%
    Dec 2016$11.32BN/A66.3%19.2%14.5%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 8.7% from the year before. In the quarter ended Sep 2026, net income fell 12.3% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$25.12B$22.59B$20.50B$18.45B$17.11B$14.35B$14.88B$13.60B$12.44B$11.32B
    Cost of revenue$9.05B$8.15B$7.44B$6.87B$6.14B$5.29B$5.19B$4.66B$4.26B$3.82B
    Gross profit$16.07B$14.44B$13.06B$11.58B$10.97B$9.06B$9.70B$8.94B$8.18B$7.50B
    Research and development$1.62B$1.47B$1.39B$1.45B$1.24B$984.00M$971.00M$862.00M$787.00M$715.00M
    Operating income$4.89B$3.69B$3.89B$2.84B$2.58B$2.22B$2.71B$2.54B$2.30B$2.17B
    Net income$3.25B$2.99B$3.17B$2.36B$1.99B$1.60B$2.08B$3.55B$1.02B$1.65B
    EBITDA$6.31B$4.95B$5.06B$3.68B$3.27B$2.77B$3.34B$3.08B$2.71B$2.47B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$6.52B$6.59B$6.02B$7.17B$6.06B$6.02B$5.87B$6.44B$5.49B$5.42B$5.24B$5.82B
    Gross profit$4.25B$4.50B$3.81B$4.63B$3.85B$3.84B$3.74B$4.17B$3.52B$3.42B$3.33B$3.70B
    Operating income$1.03B$1.66B$936.00M$1.80B$1.14B$1.11B$837.00M$581.00M$1.08B$1.05B$972.00M$1.26B
    Net income$753.00M$1.28B$745.00M$849.00M$859.00M$884.00M$654.00M$546.00M$834.00M$825.00M$788.00M$1.14B
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $15.86B exceeded cash and equivalents by $11.85B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$47.84B$42.97B$39.91B$36.88B$34.63B$34.33B$30.17B$27.23B$22.20B$20.43B
    Current assets$14.76B$14.85B$12.52B$10.28B$10.02B$9.71B$11.06B$9.73B$7.99B$7.86B
    Cash and equivalents$4.01B$3.65B$2.97B$1.84B$2.94B$2.94B$4.34B$3.62B$2.54B$3.32B
    Total liabilities$25.42B$22.34B$21.32B$20.27B$19.75B$21.25B$17.36B$15.50B$12.22B$10.88B
    Short-term debt$1.00B$1.41B$2.09B$1.19B$7.00M$761.00M$859.00M$1.37B$632.00M$228.00M
    Long-term debt$14.86B$12.19B$10.90B$11.86B$12.47B$13.23B$10.23B$8.49B$6.59B$6.69B
    Shareholder equity$22.42B$20.63B$18.59B$16.62B$14.88B$13.08B$12.81B$11.73B$9.97B$9.55B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$47.25B$47.93B$46.29B$47.84B$47.06B$46.33B$46.01B$42.97B$43.83B$39.13B$39.40B$39.91B
    Total liabilities$23.79B$23.94B$23.31B$25.42B$25.27B$25.14B$25.08B$22.34B$23.68B$19.37B$20.23B$21.32B
    Cash and equivalents$3.27B$3.39B$2.88B$4.01B$3.26B$2.38B$2.32B$3.65B$3.85B$1.87B$2.33B$2.97B
    Shareholder equity$23.46B$23.99B$22.98B$22.42B$21.79B$21.19B$20.93B$20.63B$20.15B$19.76B$19.17B$18.59B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 84.9% of operating cash flow. Dividends came to 29.9% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$5.04B$4.24B$3.71B$2.62B$3.26B$3.28B$2.19B$2.61B$1.56B$1.92B
    Capital expenditures$761.00M$755.00M$575.00M$588.00M$525.00M$487.00M$649.00M$572.00M$598.00M$490.00M
    Free cash flow$4.28B$3.49B$3.14B$2.04B$2.74B$2.79B$1.54B$2.04B$961.00M$1.43B
    Dividends paid$1.28B$1.22B$1.14B$1.05B$950.00M$863.00M$778.00M$717.00M$735.00M$568.00M
    Share repurchasesN/AN/AN/AN/AN/AN/A$307.00M$300.00M$230.00M$13.00M
    Investing cash flow-$4.87B-$3.00B-$962.00M-$2.92B-$859.00M-$4.70B-$1.46B-$2.86B-$1.61B-$4.19B
    Financing cash flow$113.00M-$525.00M-$1.59B-$749.00M-$2.37B-$11.00M$3.00M$1.33B-$794.00M$2.26B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$1.46B$1.26B$581.00M$2.14B$1.54B$1.11B$250.00M$1.93B$1.47B$633.00M$204.00M$1.53B
    Capital expenditures$237.00M$202.00M$166.00M$268.00M$187.00M$183.00M$123.00M$266.00M$170.00M$152.00M$167.00M$145.00M
    Free cash flow$1.22B$1.06B$415.00M$1.88B$1.35B$928.00M$127.00M$1.67B$1.30B$481.00M$37.00M$1.38B
    Last 12 quarters

    Frequently Asked Questions About SYK

    What is Stryker's annual revenue?

    Stryker reported revenue of $25.12B for the fiscal year ended Dec 31, 2025.

    How fast is Stryker's revenue growing?

    Revenue was up 11.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 10.8%.

    Is Stryker profitable?

    Yes. Stryker reported net income of $3.25B for the fiscal year ended Dec 31, 2025, with a net margin of 12.9%.

    How much free cash flow does SYK generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $5.04B minus capital expenditures of $761.00M produced free cash flow of $4.28B.

    How much debt does Stryker have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $14.86B, short-term debt of $1.00B and cash and equivalents of $4.01B.